Next Article in Journal
Toxicokinetics of Hydrolyzed Fumonisin B1 after Single Oral or Intravenous Bolus to Broiler Chickens Fed a Control or a Fumonisins-Contaminated Diet
Next Article in Special Issue
Scavenging Intracellular ROS Attenuates p-Cresyl Sulfate-Triggered Osteogenesis through MAPK Signaling Pathway and NF-κB Activation in Human Arterial Smooth Muscle Cells
Previous Article in Journal
Listeria monocytogenes Interferes with Host Cell Mitosis through Its Virulence Factors InlC and ActA
Previous Article in Special Issue
Uremic Toxins and Vascular Dysfunction
Review

How do Uremic Toxins Affect the Endothelium?

1
Experimental Nephrology Laboratory, Basic Pathology Department, Universidade Federal do Paraná, Curitiba 81531-980, Brazil
2
Internal Medicine Department, Division of Nephrology, Universidade Federal do Paraná, Curitiba 80060-900, Brazil
*
Author to whom correspondence should be addressed.
Received: 27 May 2020 / Revised: 15 June 2020 / Accepted: 19 June 2020 / Published: 20 June 2020
Uremic toxins can induce endothelial dysfunction in patients with chronic kidney disease (CKD). Indeed, the structure of the endothelial monolayer is damaged in CKD, and studies have shown that the uremic toxins contribute to the loss of cell–cell junctions, increasing permeability. Membrane proteins, such as transporters and receptors, can mediate the interaction between uremic toxins and endothelial cells. In these cells, uremic toxins induce oxidative stress and activation of signaling pathways, including the aryl hydrocarbon receptor (AhR), nuclear factor kappa B (NF-κB), and mitogen-activated protein kinase (MAPK) pathways. The activation of these pathways leads to overexpression of proinflammatory (e.g., monocyte chemoattractant protein-1, E-selectin) and prothrombotic (e.g., tissue factor) proteins. Uremic toxins also induce the formation of endothelial microparticles (EMPs), which can lead to the activation and dysfunction of other cells, and modulate the expression of microRNAs that have an important role in the regulation of cellular processes. The resulting endothelial dysfunction contributes to the pathogenesis of cardiovascular diseases, such as atherosclerosis and thrombotic events. Therefore, uremic toxins as well as the pathways they modulated may be potential targets for therapies in order to improve treatment for patients with CKD. View Full-Text
Keywords: uremic toxins; endothelium; endothelial dysfunction uremic toxins; endothelium; endothelial dysfunction
Show Figures

Graphical abstract

MDPI and ACS Style

Cunha, R.S.d.; Santos, A.F.; Barreto, F.C.; Stinghen, A.E.M. How do Uremic Toxins Affect the Endothelium? Toxins 2020, 12, 412. https://0-doi-org.brum.beds.ac.uk/10.3390/toxins12060412

AMA Style

Cunha RSd, Santos AF, Barreto FC, Stinghen AEM. How do Uremic Toxins Affect the Endothelium? Toxins. 2020; 12(6):412. https://0-doi-org.brum.beds.ac.uk/10.3390/toxins12060412

Chicago/Turabian Style

Cunha, Regiane S.d., Andressa F. Santos, Fellype C. Barreto, and Andréa E.M. Stinghen 2020. "How do Uremic Toxins Affect the Endothelium?" Toxins 12, no. 6: 412. https://0-doi-org.brum.beds.ac.uk/10.3390/toxins12060412

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop